Stay updated on Colistimethate Sodium in Chronic Lung Infections Clinical Trial
Sign up to get notified when there's something new on the Colistimethate Sodium in Chronic Lung Infections Clinical Trial page.

Latest updates to the Colistimethate Sodium in Chronic Lung Infections Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedAdded NIH grant/contract note: 2016 ( U.S. NIH Grant/Contract ). Updated the revision tag to Revision: v3.6.6, replacing the previous Revision: v3.6.5.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe page now displays revision v3.6.5, replacing the previous v3.6.4. This reflects a minor update to the page's revision metadata rather than a substantive change to content or features.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page footer now shows Revision: v3.6.4, replacing Revision: v3.6.3. This indicates a version update without changing the main content.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page now displays Revision: v3.6.3 instead of v3.6.2, indicating a small maintenance update to the page's revision history.SummaryDifference0.0%

- Check84 days agoChange DetectedRevision tag updated to v3.6.2 on the page, indicating a minor version update. The previous tag v3.6.0 is no longer displayed.SummaryDifference0.0%

- Check98 days agoChange DetectedThe page adds a recruitment status notice ('No longer looking for participants') and new help sections for readers (How to Read a Study Record, Common Questions, How to Join a Study). It also updates the study header formatting from 'Intervention / Treatment' to 'Intervention/Treatment' and changes the revision label to v3.6.0.SummaryDifference0.3%

Stay in the know with updates to Colistimethate Sodium in Chronic Lung Infections Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Colistimethate Sodium in Chronic Lung Infections Clinical Trial page.